Deans' stroke musings: Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, November 22, 2019

Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions

Is this enough to tell your doctor about citicoline?

Diane wrote about Bob using CerAxon here.

More here to talk to your doctor about.

citicoline (12)

Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions

Нейрометаболическая терапия в восстановительном периоде ишемического инсульта: влияние на качество жизни и когнитивные функции. Neurology, Neuropsychiatry, Psychosomatics , Volume 8(2) , Pgs. 87-93.

NARIC Accession Number: I245743. What's this?
Author(s): Zakharov V.V; Vakhnina N.V; Gromova D.O.
Publication Year: 2016.
Abstract: This paper discusses the mechanisms responsible for the process (neurogenesis, neuroplasticity, and readaptation) involved in the recovery of neurological functions following ischemic stroke (IS) and possible approaches to the drug support of cerebral reparative processes. It presents data on the rate and etiology of poststroke cognitive impairments (CI) that are one of the important factors that negatively influence the outcome of rehabilitation measures. The results obtained from a recent study of the efficacy of the neurometabolic agent citicoline in the recovery period of IS are given. The use of citicoline is shown to cause a significant regression of CI and to improve quality of life in patients who have sustained IS for the first time.
Descriptor Terms: Cognition, Drugs, Quality of life, Stroke.
Language: Russian
Geographic Location(s): Europe, Russia.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: https://nnp.ima-press.net/nnp/article/view/614/564.

Citation: Zakharov V.V, Vakhnina N.V, Gromova D.O. (2016). Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions. Нейрометаболическая терапия в восстановительном периоде ишемического инсульта: влияние на качество жизни и когнитивные функции. Neurology, Neuropsychiatry, Psychosomatics , 8(2), Pgs. 87-93. Retrieved 11/22/2019, from REHABDATA database.